A research letter spearheaded by an associate professor at the UT Health Houston School of Public Health argues that those who had cancer have similar survival rates as new cancer cases, and prior cancer should not be grounds to exclude a patient from clinical trials.

Researchers at Boston-based Mass General Cancer Center found a treatment that reduced a rare type of brain tumor by an average of 91 percent in a clinical trial.

Preoperative magnetic resonance imaging does not "significantly reduce positive margins" following breast-conserving surgery, according to trial study findings published July 10 in The Asco Post.

Luis Diaz Jr., MD, was one of the researchers who led a 2022 clinical trial of a specific type of rectal cancer with a 100 percent success rate, Fast Company reported July 6.

Here are the top five cancer hospitals in Texas, according to U.S. News & World Report rankings:

Lebanon, N.H.-based Dartmouth Health has stayed ahead of the cancer drug shortages thanks in part to its supply chain strategy, officials told The Keene Sentinel July 8.

Thirty-eight oncologists made Castle Connolly's list of top Asian American and Pacific Islander physicians.

Susan Love, MD, breast cancer surgeon, researcher and activist, died July 2 at age 75, the Los Angeles Times reported.

Charlottesville, Va.-based UVA Cancer Center is offering some patients chimeric antigen receptor T-cell therapy in an outpatient setting.

Duarte, Calif.-based City of Hope has named David Craig, PhD, professor and founding chair of the newly created department of integrative translational sciences within the Beckman Research Institute of City of Hope.

In a win for artificial intelligence, a study conducted at Baptist Health's Boca Raton (Fla.) Regional Hospital revealed the possibility of detecting breast cancer up to two years sooner using AI compared with human analysis of mammograms alone, Kathy Schilling, MD, medical director of the healthcare system's Christine E. Lynn Women's Health and Wellness Institute, told Becker's.

Here are the 10 most-read oncology stories published by Becker's in June:

Leaders from Stanford Medicine and the Department of Veterans Affairs Palo Alto Health Care System are looking to build a National Cancer Institute-designated joint cancer care and research center, according to a June 30 Stanford Medicine news release.

More oncologists are utilizing de-escalation in oncology treatment of some cancers with promising results, CNN reported July 5.

In the month since oncologists at New Hyde Park, N.Y.-based Northwell Health began using iNav — an artificial intelligence-enabled diagnostic tool developed in-house — people with pancreatic cancer have been getting "connected to care, days, if not weeks, earlier in their care trajectory" than ever before, Daniel King, MD, PhD, assistant professor at the Institute of Cancer Research at Northwell’s Feinstein Institutes for Medical Research in Manhasset, N.Y., told Becker's.

Ken Chaij, executive director of Kettering (Ohio) Health's oncology service line, said there are few things that stress him in oncology thanks to an amazing organization and a team that's willing to be creative and work together.

Four trends in oncology have emerged in the first half of 2023.

A Mass General Cancer Center study found a "striking" increase in cancer deaths among 25- to 34-year-old Hispanic men along with an increase in cancer deaths across Hispanic women.

Summit, N.J.-based Gerald J. Glasser Brain Tumor Center at Overlook Medical Center is the first in the nation to dose a patient with a glioblastoma tumor treatment aimed at increasing the effectiveness of radiation and chemotherapy.

Newsweek released its annual list of America's Best Cancer Hospitals for 2023.